News Article
Riber confirms return to profitability in 2009
RIBER, the global leader for molecular beam epitaxy (MBE), announces annual sales of € 17.3 million, of which € 7.8 million in respect of the 4th quarter
Riber confirms its guidance for a full-year net profit over 2009. Research machine sales reached a historic level of € 10.1 million, compared to € 8.1 million in 2008. The delivery of 14 MBE machines dedicated to research centers (against 13 machines sold in 2008) partly offset the lack of production system sales in the context of economic crisis.
The components and services division continued to expand and reported record sales of € 4.8 million, an increase of 30% compared to 2008. This development was driven in particular by the integration of VG Semicons business, acquired at the end of 2008.
Cell and evaporation sources sales (up 6% compared to 2008) proved resilient to the crisis due to new markets, including OLED cells which achieved sales of € 1 million in 2009. RIBERs 2009 sales were broken down between Europe (45%), Asia (41%), and North America (14%).
Confirmed return to profitability in 2009
Riber confirms its guidance for a net profit over the full financial year, combined with an improved cash position. Due to the significant progress made over the last financial year (products diversification, development of aftersales activities, higher productivity and product quality, and better cost control), Riber has sound bases that should enable it to continue growing in 2010.
The 2009 annual results will be released on March 25th 2010 (after close of trading).